tiprankstipranks
Trending News
More News >
Initiator Pharma A/S (SE:INIT)
:INIT
Sweden Market

Initiator Pharma A/S (INIT) Income Statement

Compare
0 Followers

Initiator Pharma A/S Income Statement

Last quarter (Q2 2025), Initiator Pharma A/S's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q2, Initiator Pharma A/S's net income was kr-3.86M. See Initiator Pharma A/S’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr -11.07Kkr -23.41Kkr -38.42Kkr -21.63Kkr -9.30K
Operating Expenses
kr 3.43Kkr 3.62Kkr 3.31Kkr 1.45Kkr 1.23K
Depreciation and Amortization
kr 0.00kr 0.00kr 11.00kr 11.00kr 26.00
EBITDA
kr -14.50Kkr -27.03Kkr -41.73Kkr -23.06Kkr -10.51K
Operating Income
kr -14.50Kkr -27.03Kkr -41.74Kkr -23.07Kkr -10.53K
Other Income/Expenses
kr -334.00kr -677.00kr -2.39Kkr -1.17Kkr 291.00
Pretax Income
kr -14.84Kkr -27.71Kkr -44.13Kkr -24.24Kkr -10.24K
Net Income
kr -12.93Kkr -22.87Kkr -38.45Mkr -21.06Mkr -8.70M
Per Share Metrics
Basic EPS
kr -0.23kr 0.00kr -0.80kr -0.60kr -0.32
Diluted EPS
kr -0.23kr 0.00kr -0.80kr -0.60kr -0.32
Weighted Average Shares Outstanding
55.62K 52.42M 48.33K 35.09K 27.38K
Weighted Average Shares Outstanding (Diluted)
57.27K 52.42M 48.33K 35.09K 27.38K
Currency in DKK

Initiator Pharma A/S Earnings and Revenue History